In our study, the IL-33 and IL-4 levels were not different between MGUS and MM patients (Figure 4; Table S1 in Supplementary Material), thus in MM the IL-33 level may not be sufficient to induce IL-4 and expression of FcγRIIb. Here, FCGR2B is linked to Miyoshi myopathy.